Clinical Drug Investigation

, Volume 20, Issue 5, pp 391–392 | Cite as

Comparison between an Apparently Obsolete Protocol and an Updated Regimen in the Salvage Treatment of Advanced Colorectal Cancer

  • F. Satta
  • E. Konstantatou
  • G. Nigita
  • A. Tocchi
  • M. Accordino
  • F. Franchi
Correspondence
  • 7 Downloads

Keywords

Partial Response Oxaliplatin Mitomycin Camptothecin Folinic Acid 

References

  1. 1.
    Moertel CG. Chemotherapy of gastrointestinal cancer. New Engl J Med 1978; 299: 1049–51PubMedCrossRefGoogle Scholar
  2. 2.
    The Advanced Colorectal Meta-Analysis Project. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 1994; 12: 960–9Google Scholar
  3. 3.
    The Meta-Analysis Group in Cancer. Efficacy of intravenous continous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998; 16: 301–8Google Scholar
  4. 4.
    Satta F, Franchi F, Gargano L et al. Modulation of continous infusion 5-fluorouracil (5-FU) with weekly methotrexate (Mtx). AACR 1999; 40: [abstract] 554Google Scholar
  5. 5.
    Frank W, Osterberg AE. Mitomycin C (NSC — 26980) — An evaluation of Japanese reports. Cancer Chemother Rep 1960; 9: 114–9PubMedGoogle Scholar
  6. 6.
    Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47: 207–11PubMedCrossRefGoogle Scholar
  7. 7.
    Zaffaroni N, Bearzatto A, Gornati D et al. Effect of lonidamine on the cytotoxic activity of cisplatin, mitomycin C and BCNU in human ovarian and colon carcinoma cells. Int J Oncol 1994; 4: 773–8Google Scholar
  8. 8.
    Franchi F, Seminara P, Codacci Pisanelli G et al. Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow trasplantation in the treatment of advanced colorectal cancer: results from a pilot study. Eur J Cancer 1994; 30A 10: 1420–3CrossRefGoogle Scholar

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  • F. Satta
    • 1
    • 2
  • E. Konstantatou
    • 1
    • 2
  • G. Nigita
    • 1
    • 2
  • A. Tocchi
    • 1
    • 2
  • M. Accordino
    • 1
    • 2
  • F. Franchi
    • 1
    • 2
  1. 1.Department of Clinical Medicine, Oncology UnitUniversity of Rome ‘La Sapienza’ Surgical Clinic, Casilino HospitalRomeItaly
  2. 2.First Department of SurgeryUniversity of Rome ‘La Sapienza’RomeItaly

Personalised recommendations